Valuation: G MEDPAR

Market Cap 723K 626K 587K 535K 1.01M 68.96M 1.02M 6.9M 2.7M 34.53M 2.71M 2.66M 115M P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 2.52M 2.18M 2.05M 1.87M 3.51M 240M 3.56M 24.06M 9.4M 120M 9.46M 9.26M 401M EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.03
3 years 0
Extreme 1.0E-6
0.36
5 years 0
Extreme 1.0E-6
235.9
10 years 0
Extreme 1.0E-6
235.9
Manager TitleAgeSince
Chief Executive Officer 75 03/10/2014
Director of Finance/CFO 46 31/07/2022
Chief Tech/Sci/R&D Officer 56 01/12/2017
Director TitleAgeSince
Director/Board Member 75 03/10/2014
Chairman 72 21/08/2014
Director/Board Member 76 24/02/2017
Date Insider Type Main position Quantity % Market Cap.
3/31/23 A
AWM Investment Co., Inc.
SellCompany 737,500 37.5554%
3/31/23 A
AWM Investment Co., Inc.
OtherCompany 1,437,500 73.2011%

Financials

2021 2022
Net sales 5.06M 4.38M 4.11M 3.75M 7.04M 482M 7.15M 48.29M 18.88M 242M 18.99M 18.58M 805M 4.42M 3.83M 3.59M 3.27M 6.15M 422M 6.25M 42.2M 16.5M 211M 16.6M 16.23M 704M
Net income -14.76M -12.79M -11.98M -10.93M -20.54M -1.41B -20.86M -141M -55.08M -705M -55.41M -54.21M -2.35B -13.52M -11.71M -10.98M -10.01M -18.82M -1.29B -19.11M -129M -50.46M -646M -50.77M -49.66M -2.15B
Net Debt 2.41M 2.09M 1.95M 1.78M 3.35M 230M 3.4M 22.99M 8.99M 115M 9.04M 8.84M 383M 1.8M 1.56M 1.46M 1.33M 2.5M 171M 2.54M 17.16M 6.71M 85.82M 6.75M 6.6M 286M
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
-
Sector
-
Date Price Change Volume
11/08/26 $0.000100 0.00% 528
  1. Stock Market
  2. Stocks
  3. GMVDF Stock